Literature DB >> 1390660

Catalytic center of cyclodextrin glycosyltransferase derived from X-ray structure analysis combined with site-directed mutagenesis.

C Klein1, J Hollender, H Bender, G E Schulz.   

Abstract

An X-ray structure analysis of a crystal of mutant Asp229----Ala of cyclodextrin glycosyltransferase from Bacillus circulans (Ec 2.4.1.19) that had been shortly exposed to beta-cyclodextrin showed density corresponding to a maltose bound at the catalytic center. The crystal structure was refined to an R-factor of 18.7% at 2.5-A resolution. The catalytic center is defined by homology with the structurally known alpha-amylases and by the observation that mutants Asp229----Ala and Asp328----Ala are almost inactive. By model building, the density-defined maltose was extended to a full beta-cyclodextrin, which then indicated the general locations of seven subsites for glucosyl units. The catalytically competent residues Asp229, Glu257, and Asp328 are at the reducing end of the density-defined maltose. In the unligated wild-type structure, Glu257 and Asp328 form a 2.6-A hydrogen bond between their carboxylates in an arrangement that resembles those of the catalytically competent carboxylates in acid proteases. Presumably, the first catalytic step is an attack of the proton between Glu257 and Asp328 on the oxygen of the glycosidic bond.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1390660     DOI: 10.1021/bi00152a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Calculating pKa values in enzyme active sites.

Authors:  Jens Erik Nielsen; J Andrew McCammon
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

2.  Sequence analysis of the gene encoding amylosucrase from Neisseria polysaccharea and characterization of the recombinant enzyme.

Authors:  G P De Montalk; M Remaud-Simeon; R M Willemot; V Planchot; P Monsan
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

3.  Knowledge-based model of a glucosyltransferase from the oral bacterial group of mutans streptococci.

Authors:  K S Devulapalle; S D Goodman; Q Gao; A Hemsley; G Mooser
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

4.  Cloning, mutagenesis, and structural analysis of human pancreatic alpha-amylase expressed in Pichia pastoris.

Authors:  E H Rydberg; G Sidhu; H C Vo; J Hewitt; H C Côte; Y Wang; S Numao; R T MacGillivray; C M Overall; G D Brayer; S G Withers
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

Review 5.  Approaches to labeling and identification of active site residues in glycosidases.

Authors:  S G Withers; R Aebersold
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

6.  Characteristic differences in the primary structure allow discrimination of cyclodextrin glucanotransferases from alpha-amylases.

Authors:  S Janecek; E A MacGregor; B Svensson
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

Review 7.  Protein engineering in the alpha-amylase family: catalytic mechanism, substrate specificity, and stability.

Authors:  B Svensson
Journal:  Plant Mol Biol       Date:  1994-05       Impact factor: 4.076

8.  Improved activity of β-cyclodextrin glycosyltransferase from Bacillus sp. N-227 via mutagenesis of the conserved residues.

Authors:  Hua Wang; Wenxi Zhou; Hua Li; Bu Rie; Chunhong Piao
Journal:  3 Biotech       Date:  2017-06-08       Impact factor: 2.406

9.  Expression of the isoamylase gene of Flavobacterium odoratum KU in Escherichia coli and identification of essential residues of the enzyme by site-directed mutagenesis.

Authors:  J Abe; C Ushijima; S Hizukuri
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

Review 10.  Engineering of cyclodextrin glucanotransferases and the impact for biotechnological applications.

Authors:  Hans Leemhuis; Ronan M Kelly; Lubbert Dijkhuizen
Journal:  Appl Microbiol Biotechnol       Date:  2009-09-18       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.